Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European population

No abstract is available for this paper.

• Publication year

  1998

• Venue

  British Journal of Pharmacology

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjp.0702152PMID 9831928PMCID PMC1571045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity

  2004cited by this paper
• Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.

  1999cited by this paper
• Pharmacokinetics, dose adjustments, and 6‐mercaptopurine/ methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency

  1998cited by this paper
• Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

  1998cited by this paper
• Detection of known and new mutations in the thiopurine S‐methyltransferase gene by single‐strand conformation polymorphism analysis

  1998cited by this paper
• Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms

  1997influential reference
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

  1997influential reference
• Promoter and Intronic Sequences of the Human Thiopurine S-Methyltransferase (TPMT) Gene Isolated from a Human Pacl Genomic Library

  1997cited by this paper
• Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells.

  1997cited by this paper
• Human thiopurine methyltransferase pharmacogenetics: Identification of a novel variant allele

  1996cited by this paper
• Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide

  1996cited by this paper
• Thiopurine methyltransferase activity in a Korean population sample of children

  1996cited by this paper
• Thiopurine Methyltransferase Pharmacogenetics: Human Gene Cloning and Characterization of a Common Polymorphism

  1996influential reference
• Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.

  1996influential reference
• Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.

  1996cited by this paper
• Erythrocyte thiopurine methyltransferase activity in a Korean population.

  1996cited by this paper
• Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.

  1995cited by this paper
• A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.

  1995influential reference
• Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients.

  1995cited by this paper
• Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults.

  1995cited by this paper
• Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation.

  1995cited by this paper
• Segregation analysis of human red blood cell thiopurine methyltransferase activity

  1995cited by this paper
• Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1.

  1995cited by this paper
• Thiopurine methyltransferase activity in American white subjects and black subjects

  1994cited by this paper
• Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors.

  1994cited by this paper
• Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

  1993cited by this paper
• Thiopurine methyltransferase activity in a sample population of black subjects in Florida

  1993cited by this paper
• Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

  1993cited by this paper
• Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.

  1993cited by this paper
• THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS1

  1992cited by this paper
• Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.

  1992cited by this paper
• Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia.

  1991cited by this paper
• Thiopurine methyltransferase in humans: development and tissue distribution.

  1991cited by this paper
• Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.

  1990cited by this paper
• Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism

  1989cited by this paper
• Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6‐thioguanine nucleotide concentrations

  1987cited by this paper
• Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies.

  1982cited by this paper
• Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

  1980influential reference
• Thiol S‐methylation in uremia: Erythrocyte enzyme activities and plasma inhibitors

  1980cited by this paper
• Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.

  1978cited by this paper

• Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease

  2025cites this paper
• Pharmaco-epigenetics: Histone modification and personalized medicine

  2023cites this paper
• TRANSCRIPTOME ANALYSIS REVEALS INVOLVEMENT OF THIOPURINE S-METHYLTRANSFERASE IN OXIDATION-REDUCTION PROCESSES.

  2023cites this paper
• Biomarkers for gastrointestinal adverse events related to thiopurine therapy

  2021cites this paper
• No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study

  2021cites this paper
• Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.

  2021cites this paper
• Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia

  2020cites this paper
• Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis

  2020cites this paper
• NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine‐induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India

  2020cites this paper
• Long‐term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine

  2019cites this paper
• Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.

  2019cites this paper
• Pharmacogenetics of Thiopurine Drugs: Role of Thiopurine S-Methyltransferase and Nucleoside Diphosphate-Linked Moiety X Motif 15 Genetic Polymorphisms on Drugs-induced Myelosuppression

  2019cites this paper
• PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients

  2019cites this paper
• Frequency of thiopurine S-methyltransferase gene variations in Turkish children with acute leukemia.

  2018cites this paper
• Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis

  2018cites this paper
• Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT*3 alleles.

  2018cites this paper
• Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods

  2017cites this paper
• Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia

  2017cites this paper
• Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).

  2017cites this paper
• In-depth analysis of factors affecting variability in thiopurine methyltransferase activity

  2017cites this paper
• Pharmacogénétique des immunosuppresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)

  2017cites this paper
• One amino acid makes a difference–Characterization of a new TPMT allele and the influence of SAM on TPMT stability

  2017cites this paper
• Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease

  2016cites this paper
• Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines.

  2016cites this paper
• Development of genotyping systems for pharmacogenomics profiling

  2016cites this paper
• Optimising the use of Azathioprine in the treatment of Inflammatory Bowel Disease

  2016cites this paper
• Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy

  2016cites this paper
• Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants.

  2015cites this paper
• Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

  2015cites this paper
• Thiopurine S-methyltransferase Testing for Averting Drug Toxicity in Patients Receiving Thiopurines: A meta-analysis of diagnostic test accuracy

  2015influential citation
• TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner.

  2015cites this paper
• Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.

  2015cites this paper
• Development of a rapid clinical TPMT genotyping assay.

  2014cites this paper
• Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring.

  2014cites this paper
• Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

  2014cites this paper
• Therapeutic drug monitoring in patients with inflammatory bowel disease.

  2014cites this paper
• Optimisation de la réponse aux thiopurines par la pharmacogénétique : approches in vitro et cliniques

  2014influential citation
• A New Thiopurine S‐Methyltransferase Haplotype Associated With Intolerance to Azathioprine

  2013cites this paper
• Nomenclature for alleles of the thiopurine methyltransferase gene

  2013cites this paper
• Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population

  2013cites this paper
• Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.

  2013cites this paper
• High-Resolution Melting Analysis of the TPMT Gene: A Study in the Polish Population

  2013cites this paper
• Thiopurine S-Methyltransferase Phenotype and Genotype in Pediatric Patients with Inflammatory Bowel Disease; Implication for AzathioprineTreatment

  2013cites this paper
• Preanalytical stringency: what factors may confound interpretation of thiopurine S-methyl transferase enzyme activity?

  2013cites this paper
• Pharmacogenomics of Pulmonary and Respiratory Diseases

  2013cites this paper
• Prediction of Chemotherapy Toxicities

  2013cites this paper
• A study on Pharmacogenetic polymorphisms in the Portuguese Gypsies

  2013cites this paper
• Alelos de tiopurina metiltransferasa en población colombiana

  2013cites this paper
• Pharma-Pharmacogenetics in inflammatory bowel disease

  2013cites this paper
• Let's get personal: predicting thiopurine and fluoropyrimidine toxicity.

  2012cites this paper
• Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes.

  2012cites this paper
• Allele frequency of inosine triphosphate pyrophosphatase (ITPA) and thiopurine-S-methyl transferase (TPMT) genes in the Tunisian population.

  2012cites this paper
• Gene Polymorphisms Involved in Manifestation of Leucopenia, Digestive Intolerance, and Pancreatitis in Azathioprine-Treated Patients

  2012cites this paper
• Provisional chapter Gene Polymorphisms and Inflammatory Bowel Diseases

  2012cites this paper
• Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia

  2012cites this paper
• [Significance of thiopurine s-methyltransferase gene test in a clinical case].

  2012cites this paper
• Pharmacogenomics of Thiopurine S-Methyltransferase: Clinical Applicability of Genetic Variants

  2012influential citation
• Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy.

  2012cites this paper
• 6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner.

  2012cites this paper
• Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

  2012cites this paper
• Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCR.

  2012cites this paper
• Gene Polymorphisms and Inflammatory Bowel Diseases

  2012cites this paper
• Importance of thiopurine s-methyltransferase gene test

  2012cites this paper
• Transcriptional regulation and pharmacogenomics.

  2011cites this paper
• Drug metabolizing enzymes activities versus genetic variances for drug of clinical pharmacogenomic

  2011cites this paper
• The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population

  2011cites this paper
• Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance

  2011cites this paper
• Clinical applicability of sequence variations in genes related to drug metabolism.

  2011cites this paper
• Towards predictive pharmacogenetic profiling for azathioprine treatment: characterization of SNPs in relevant drug metabolism genes

  2011cites this paper
• Interindividual differences in thiopurine metabolism : studies with focus on inflammatory bowel disease

  2011cites this paper
• Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.

  2011cites this paper
• INDIVIDUALIZED THERAPY: ROLE OF THIOPURINE S-METHYLTRANSFERASE PROTEIN AND GENETIC VARIANTS INDIVIDUALIZOVANA TERAPIJA: ULOGA PROTEINSKIH I GENETSKIH VARIJANTI TIOPURIN S-METILTRANSFERAZE

  2010cites this paper
• [Therapeutic drug monitoring of 6-thioguanine nucleotides in paediatric acute lymphoblastic leukaemia: interest and limits].

  2010cites this paper
• Individualized Therapy: Role of Thiopurine S-Methyltransferase Protein and Genetic Variants

  2010cites this paper
• Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine

  2010cites this paper
• Thiopurine S-methyltransferase deficiency associated with a novel mutation.

  2010cites this paper
• Functional analysis of the role of the TPMT gene promoter VNTR polymorphism in TPMT gene transcription.

  2010cites this paper
• [Not Available].

  2010cites this paper
• TPMT gene polymorphisms: on the doorstep of personalized medicine.

  2009cites this paper
• Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity.

  2009cites this paper
• Thiopurine S‐methyltransferase (TPMT) genetic polymorphisms in Mexican newborns

  2009cites this paper
• Pharmacogenomics of anticoagulants: steps toward personal dosage

  2009cites this paper
• PHARMACOGENETIQUE DES MEDICAMENTS THIOPURINIQUES Implication des enzymes TPMT et IMPDH2 et de la RhoGTPase RAC1

  2009cites this paper
• Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.

  2009cites this paper
• Azathioprine/6-mercaptopurine toxicity: The role of the TPMT gene

  2008cites this paper
• Thiopurine S-Methyltransferase (TPMT) Gene Polymorphism in Brazilian Children With Acute Lymphoblastic Leukemia: Association With Clinical and Laboratory Data

  2008cites this paper
• Characterisation of novel defective thiopurine S-methyltransferase allelic variants.

  2008cites this paper
• Regulatory Polymorphisms and their Contribution to Interindividual Differences in the Expression of Enzymes Influencing Drug and Toxicant Disposition

  2008cites this paper
• CYP2C9 Genotype‐guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study

  2008cites this paper
• Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore

  2008cites this paper
• Multiple thiopurine S-methyltransferase variation detection: a step toward personalized medicine.

  2008cites this paper
• PhRMA White Paper on ADME Pharmacogenomics

  2008cites this paper
• Thiopurine S-methyltransferase genotypic analysis in autoimmune bullous diseases.

  2008cites this paper
• Start low, go slow, but don't go this way yet.

  2008cites this paper
• Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease.

  2008cites this paper
• Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity

  2008cites this paper
• The low frequency of defective TPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia

  2007cites this paper
• Thiopurine Methyltransferase Activity in Spain: A Study of 14,545 Patients

  2007cites this paper
• Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).

  2007cites this paper
• Search for functional alleles in the human genome with focus on cardiovascular disease candidate genes.

  2007cites this paper